具有新型EPS15:BRAF融合和先天性特征的黑色细胞瘤
Shruti Agrawal1, Ruifeng Ray Guo2
1Department of Dermatology, Mayo Clinic, Rochester, MN; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Human pathology
|May 15, 2025
概括
在黑色细胞病变中发现了一种新的EPS15::BRAF融合,扩大了已知的BRAF改变的瘤谱. 需要进一步的研究来确定这些独特的黑色细胞瘤的临床预后.
科学领域:
- 皮肤病理学 皮肤病理学
- 在瘤学瘤学.
- 分子诊断学 分子诊断学
背景情况:
- 报告一种罕见的黑色细胞病变,其特点是新型EPS15::BRAF融合.
- 突出显著的基因病理特征使其与斯皮茨类瘤有所区别.
研究的目的:
- 报告一种带有新型EPS15::BRAF融合的黑色细胞病变病例.
- 为了描述这种病变的独特基因病理特征.
- 扩大对BRAF融合的黑色细胞瘤的形态谱的理解.
主要方法:
- 黑色细胞病变的组织病理学检查.
- 分子分析以确定基因融合,特别针对BRAF变异.
- 形态特征与已知的Spitzoid瘤和其他BRAF改变的病变的比较.
主要成果:
- 在黑色细胞病变中发现了一种新的EPS15::BRAF融合.
- 病变表现出明显的组织病理特征,不同于典型的Spitzoid瘤.
- 这一发现扩大了BRAF融合病变的范围,包括先天性类型的nevoid黑色细胞病变.
结论:
- 新的EPS15::BRAF融合代表了黑色细胞瘤中一个新的分子亚型.
- 先天性类型的内性黑色细胞病变可以容纳BRAF融合.
- 长期的临床随访对于阐明这种融合的黑色细胞新生瘤的预后至关重要.
相关概念视频
Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K


